Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China

BACKGROUND: There is a paucity of large‐scale studies evaluating the clinical benefit of the Gaviscon Double Action (DA) alginate‐antacid formulation for treating gastroesophageal reflux disease (GERD) symptoms. AIM: Randomised double‐blind placebo‐controlled parallel‐group study to evaluate efficac...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Aliment Pharmacol Ther
Egile Nagusiak: Sun, J., Yang, C., Zhao, H., Zheng, P., Wilkinson, J., Ng, B., Yuan, Y.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2015
Gaiak:
Randomised Clinical Trials
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5042071/
https://ncbi.nlm.nih.gov/pubmed/26228097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13334
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak